Fig. 1From: Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progressionImpact of the SNP NPAS2 rs6542993 on prostate cancer progression. Kaplan–Meier estimates of a biochemical recurrence (BCR)-free survival in localized prostate cancer patients who received radical prostatectomy, and b progression-free survival in patients with advanced prostate cancer who received androgen-deprivation therapy (ADT) according to NPAS2 rs6542993 genotypesBack to article page